Universal Health Services Inc. (UHS): 2Q First Take: EBITDA Miss on Softer Acute Pricing / Margins; Slight Guidance Cut Opted vs. Material 2H26 Derisking

Research evidence excerpt

Universal Health Services Inc. (UHS): 2Q First Take: EBITDA Miss on Softer Acute Pricing / Margins; Slight Guidance Cut Opted vs. Material 2H26 Derisking

008) unless otherwise agreed by Goldman Sachs. A copy of certain Goldman Sachs Australia and New Zealand disclosure of interests is available at:

https://www.goldmansachs.com/disclosures/australia-new-zealand/index.html. Russia: Research reports distributed in the Russian Federation are not

advertising as defined in the Russian legislation, but are information and analysis not having product promotion as their main purpose and do not

provide appraisal within the meaning of the Russian legislation on appraisal activity. Research reports do not constitute a personalized investment

recommendation as defined in Russian laws and regulations, are not addressed to a specific client, and are prepared without analyzing the financial

circumstances, investment profiles or risk profiles of clients. Goldman Sachs assumes no responsibility for any investment decisions that may be taken

by a client or any other person based on this research report. Singapore: Goldman Sachs (Singapore) Pte. (Company Number: 198602165W), which is

regulated by the Monetary Authority of Singapore, accepts legal responsibility for this research, and should be contacted with respect to any matters

arising from, or in connection with, this research. Taiwan: This material is for reference only and must not be reprinted without permission. Investors

should carefully consider their own investment risk. Investment results are the responsibility of the individual investor. United Kingdom: Persons who

would be categorized as retail clients in the United Kingdom, as such term is defined in the rules of the Financial Conduct Authority, should read this